2‐Substituted 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity
暂无分享,去创建一个
I. Pichová | Michal Hocek | P. Džubák | J. Stolaříková | L. Slavětínská | M. Hajdůch | J. Snášel | Petr Nauš | Vincent Malnuit
[1] Helena Zábranská,et al. Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides. , 2014, Journal of medicinal chemistry.
[2] Michal Hocek,et al. Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides. , 2014, Journal of medicinal chemistry.
[3] I. Pichová,et al. 6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents , 2013 .
[4] Michal Hocek,et al. Synthesis and Cytostatic and Antiviral Activities of 2′‐Deoxy‐2′,2′‐difluororibo‐ and 2′‐Deoxy‐2′‐fluororibonucleosides Derived from 7‐(Het)aryl‐7‐deazaadenines , 2013, ChemMedChem.
[5] Michal Hocek,et al. Synthesis of 2′-deoxy-2′-fluororibo- and 2′-deoxy-2′,2′-difluororibonucleosides derived from 6-(het)aryl-7-deazapurines , 2012 .
[6] R. Pohl,et al. Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides. , 2012, Bioorganic & medicinal chemistry.
[7] S. Juršėnas,et al. Synthesis of 4-aryl-, 2,4-diaryl- and 2,4,7-triarylpyrrolo[2,3-d]pyrimidines by a combination of the Suzuki cross-coupling and N-arylation reactions , 2012 .
[8] I. Pichová,et al. Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines. , 2011, Journal of medicinal chemistry.
[9] C. Cameron,et al. Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. , 2010, Journal of medicinal chemistry.
[10] Helena Zábranská,et al. CycloSal‐phosphate Pronucleotides of Cytostatic 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Cytostatic Activity, and Inhibition of Adenosine Kinases , 2010, ChemMedChem.
[11] R. Pohl,et al. 6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents. , 2010, Journal of medicinal chemistry.
[12] C. K. Chu,et al. Structure-activity relationships of 7-deaza-6-benzylthioinosine analogues as ligands of Toxoplasma gondii adenosine kinase. , 2008, Journal of medicinal chemistry.
[13] J. Sacchettini,et al. High Resolution Crystal Structures of Mycobacterium tuberculosis Adenosine Kinase , 2007, Journal of Biological Chemistry.
[14] W. Parker,et al. Purine metabolism in Mycobacterium tuberculosis as a target for drug development. , 2007, Current pharmaceutical design.
[15] W. Parker,et al. Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety. , 2006, Biochemical pharmacology.
[16] M. Erion,et al. Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues. , 2005, Journal of Medicinal Chemistry.
[17] M. Otto,et al. Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides. , 2005, Journal of medicinal chemistry.
[18] R. Pohl,et al. Highly Methylated Purines and Purinium Salts as Analogues of Heteromines , 2005 .
[19] B. Ugarkar,et al. Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition. , 2005, Journal of medicinal chemistry.
[20] P. D. Cook,et al. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. , 2004, Journal of medicinal chemistry.
[21] M. Erion,et al. Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides. , 2003, Journal of medicinal chemistry.
[22] P. Gannett,et al. Efficient one-step Suzuki arylation of unprotected halonucleosides, using water-soluble palladium catalysts. , 2003, The Journal of organic chemistry.
[23] Michal Hocek,et al. An efficient synthesis of 2-substituted 6-methylpurine bases and nucleosides by Fe- or Pd-catalyzed cross-coupling reactions of 2,6-dichloropurines. , 2003, The Journal of organic chemistry.
[24] Z. Janeba,et al. Efficient syntheses of 2-chloro-2'-deoxyadenosine (cladribine) from 2'-deoxyguanosine(1). , 2003, The Journal of organic chemistry.
[25] Z. Janeba,et al. Nucleic acid related compounds. 116. Nonaqueous diazotization of aminopurine nucleosides. Mechanistic considerations and efficient procedures with tert-butyl nitrite or sodium nitrite. , 2002, The Journal of organic chemistry.
[26] M. Erion,et al. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. , 2000, Journal of medicinal chemistry.
[27] J. Montgomery,et al. Convenient Syntheses of 6-Methylpurine and Related Nucleosides , 2000, Nucleosides, nucleotides & nucleic acids.
[28] Michal Hocek,et al. Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki-Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids. , 2000, Journal of medicinal chemistry.
[29] G. Gillespie,et al. Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. , 1998, Biochemical pharmacology.
[30] Yukio,et al. Convenient Method for the Synthesis of C-Alkylated Purine Nucleosides : Palladium-Catalyzed Cross-Coupling Reaction of Halogenopurine Nucleosides with Trialkylaluminums. , 1992 .
[31] T. Soulimane,et al. 2,4‐Disubstituted Pyrrolo[2,3‐d]pyrimidine α‐D‐ and β‐D‐Ribofuranosides Related to 7‐Deazaguanosine , 1990 .
[32] F. Seela,et al. Stereoselective synthesis of pyrrolo[2,3‐d]pyrimidine α‐ and β‐D‐ribonucleosides from anomerically pure D‐ribofuranosyl chlorides: Solid‐Liquid Phase‐Transfer Glycosylation and 15N‐NMR Spectra , 1988 .
[33] F. Denizot,et al. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.
[34] R. West,et al. 2-Alkyl(aryl)- and 2,7-Dimethyl-4-substituted Aminopyrrolo [2,3-d] pyrimidines , 1961 .
[35] A. Villela,et al. Pyrimidine salvage pathway in Mycobacterium tuberculosis. , 2011, Current medicinal chemistry.
[36] R. Pohl,et al. Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides. , 2011, Bioorganic & medicinal chemistry.
[37] Michal Hocek,et al. CYTOSTATIC 6-ARYLPURINE NUCLEOSIDES IV + . SYNTHESIS OF 2-SUBSTITUTED 6-PHENYLPURINE RIBONUCLEOSIDES , 2002 .
[38] Michal Hocek,et al. Cytostatic 6-Arylpurine Nucleosides III. Synthesis and Structure-Activity Relationship Study in Cytostatic Activity of 6-Aryl-, 6-Hetaryl- and 6-Benzylpurine Ribonucleosides , 2001 .
[39] R. M. Otoski,et al. Stereoselective preparations of ribofuranosyl chlorides and ribofuranosyl acetates.Solvent effects and stereoselectivity in the reaction of ribofuranosyl acetates with trimethylallylsilane , 1986 .